Welcome Guest User | Login or Register

Investor Relations

Investor Relations

STERIS plc is a leading provider of infection prevention and procedural surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical device companies. Our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.

NYSE   |   STE (common stock)
$69.21 + 0.66
Stock chart for: STE.  Currently trading at $69.21 with a 52 week high of $74.63 and a 52 week low of $61.64.
02/21/17 12:04 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent Press Releases

STERIS plc Announces Financial Results for Fiscal 2017 Third Quarter

Read More

STERIS plc to Announce Fiscal 2017 Third Quarter Financial Results on February 7, 2017

Read More

STERIS plc Announces Financial Results for Fiscal 2017 Second Quarter

Read More

Investor Events

Tuesday, February 7, 2017 
10:00 a.m. ET
Q3 2017 STERIS plc Earnings Conference Call
Wednesday, November 2, 2016 
10:00 a.m. ET
Q2 2017 STERIS plc Earnings Conference Call